AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Orivog GM 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Nexkem Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Orivog GM 2mg/500mg/0.3mg Tablet SR

Diabetic patients may benefit from Glymoria, a triple-combination anti-diabetic medication (2mg/500mg/0.3mg SR). This formulation aids in managing type 2 diabetes mellitus in adults by regulating blood glucose. Glymoria should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood glucose monitoring. Consistent use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks hyperglycemia, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight control as directed by your doctor. The most prevalent adverse effect is hypoglycemia. Familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (rapid-acting glucose sources like juice or candy). Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Glymoria is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose checks, along with blood cell and liver function monitoring via blood tests, are recommended by your physician.

Primary Ingredients of Orivog GM 2mg/500mg/0.3mg Tablet SR

No text provided to rephrase.

Uses of Orivog GM 2mg/500mg/0.3mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Orivog GM 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Orivog GM 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet on an empty stomach.

Common Side effects of Orivog GM 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Orivog GM 2mg/500mg/0.3mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Orivog GM 2mg/500mg/0.3mg Extended-Release Tablets on an empty stomach.

How Orivog GM 2mg/500mg/0.3mg Tablet SR works:

Orivog GM extended-release tablets (2mg/500mg/0.3mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Orivog GM 2mg/500mg/0.3mg SR tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Orivog GM 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Orivog GM 2mg/500mg/0.3mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly causing infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Orivog GM 2mg/500mg/0.3mg Tablet SR is likely unsafe for individuals with kidney impairment and should be disregarded. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Orivog GM 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction typically begin on a reduced Orivog GM 2mg/500mg/0.3mg Tablet SR dosage; however, its administration is contraindicated in those with severe liver disease.

What if you forget to take Orivog GM 2mg/500mg/0.3mg Tablet SR :

Should you forget to take your Orivog GM 2mg/500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Orivog GM 2mg/500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Orivog GM 2mg/500mg/0.3mg Tablet SR

Orivog GM tablets (Glimepiride 2mg/Metformin 500mg/Voglibose 0.3mg SR) combine three medications to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; Metformin reduces liver glucose production and enhances insulin sensitivity; and Voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Orivog GM 2mg/500mg/0.3mg Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Orivog GM 2mg/500mg/0.3mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Orivog GM 2mg/500mg/0.3mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Orivog GM 2mg/500mg/0.3mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Orivog GM 2mg/500mg/0.3mg...
111
MRP 135
17% off